Silo Pharma, Inc. - 8-K Filing
Silo Pharma, Inc. executed a 1-for-15 reverse stock split effective June 2, 2026, reducing its authorized common shares from 100 million to 6.67 million and adjusting outstanding equity awards proportionally. The company’s stock began trading on Nasdaq under the same symbol 'SILO' with a new CUSIP number (82711P300). (Items: 3.03 Material Modification to Rights of Security Holders, 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $SILO